NCT00195000View on ClinicalTrials.gov

Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

February 29, 2008

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Interventions
DRUG

Mylotarg

6 mg/m2 on day 1

DRUG

Cytarabine

100 mg/m2 given as continuous infusion daily for 7 days.

Trial Locations (1)

10021

Weill Medcial College of Cornell University, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT00195000 - Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS | Biotech Hunter | Biotech Hunter